| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ph Hoigné, C H Attenhofer Jost, F Duru, E N Oechslin, B Seifert, U Widmer, B Frischknecht, R Jenn. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. International journal of cardiology. vol 111. issue 3. 2007-01-03. PMID:16307805. |
simple criteria for differentiation of fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. |
2007-01-03 |
2023-08-12 |
Not clear |
| Ph Hoigné, C H Attenhofer Jost, F Duru, E N Oechslin, B Seifert, U Widmer, B Frischknecht, R Jenn. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy. International journal of cardiology. vol 111. issue 3. 2007-01-03. PMID:16307805. |
fabry disease may be difficult to differentiate from other causes of left ventricular hypertrophy such as other myocardial storage diseases (including amyloidosis), hypertrophic cardiomyopathy (hcm), or hypertensive heart disease (hhd). |
2007-01-03 |
2023-08-12 |
Not clear |
| Frédéric Barbey, Noureddine Brakch, Ales Linhart, Nathalie Rosenblatt-Velin, Xavier Jeanrenaud, Salah Qanadli, Beat Steinmann, Michel Burnier, Tomas Palecek, Jan Bultas, Daniel Hayo. Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arteriosclerosis, thrombosis, and vascular biology. vol 26. issue 4. 2006-07-14. PMID:16469946. |
cardiac and vascular hypertrophy in fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. |
2006-07-14 |
2023-08-12 |
mouse |
| Christopher L Owens, Stuart D Russell, Marc K Halushk. Histologic and electron microscopy findings in myocardium of treated Fabry disease. Human pathology. vol 37. issue 6. 2006-07-10. PMID:16733219. |
the well-described histologic and electron microscopic findings in fabry disease cardiomyopathy are hypertrophic vacuolated cells with electron dense concentric lamellar bodies. |
2006-07-10 |
2023-08-12 |
Not clear |
| Hiroshi Hasegawa, Hiroyuki Takano, Satoshi Shindo, Shinichi Takeda, Nobusada Funabashi, Keiichi Nakagawa, Tetsuya Toyozaki, Yoichi Kuwabara, Issei Komur. Images in cardiovascular medicine. Transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of Fabry disease. Circulation. vol 113. issue 16. 2006-05-04. PMID:16636179. |
transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of fabry disease. |
2006-05-04 |
2023-08-12 |
Not clear |
| Liza Thomas, Norman Sadic. A case of Fabry disease mimicking hypertrophic cardiomyopathy. Heart, lung & circulation. vol 13. issue 2. 2006-01-12. PMID:16352193. |
a case of fabry disease mimicking hypertrophic cardiomyopathy. |
2006-01-12 |
2023-08-12 |
Not clear |
| J Strotmann, F Weidemann, F Breunig, A Knoll, C Wanner, G Ert. Morbus Fabry of the heart. Why should cardiologists care? Zeitschrift fur Kardiologie. vol 94. issue 9. 2005-12-07. PMID:16142514. |
this implied the hypothesis that some of those patients with unexplained myocardial hypertrophy do suffer from fabry disease. |
2005-12-07 |
2023-08-12 |
Not clear |
| Sudheera Magage, Ales Linhart, Jan Bultas, Jan Vojacek, Martin Mates, Tomas Palecek, Jana Popelová, Jaroslav Tintera, Michael Aschermann, Martin E Goldman, Robert J Desnic. Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. Echocardiography (Mount Kisco, N.Y.). vol 22. issue 4. 2005-09-01. PMID:15839990. |
fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. |
2005-09-01 |
2023-08-12 |
Not clear |
| Sudheera Magage, Ales Linhart, Jan Bultas, Jan Vojacek, Martin Mates, Tomas Palecek, Jana Popelová, Jaroslav Tintera, Michael Aschermann, Martin E Goldman, Robert J Desnic. Fabry disease: percutaneous transluminal septal myocardial ablation markedly improved symptomatic left ventricular hypertrophy and outflow tract obstruction in a classically affected male. Echocardiography (Mount Kisco, N.Y.). vol 22. issue 4. 2005-09-01. PMID:15839990. |
fabry disease (alpha-galactosidase a deficiency) is an x-linked recessive lysosomal storage disease in which left ventricular hypertrophy (lvh) is common, and if severe, may mimic hypertrophic obstructive cardiomyopathy. |
2005-09-01 |
2023-08-12 |
Not clear |
| J S Shah, P M Elliot. Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapy. Acta paediatrica (Oslo, Norway : 1992). Supplement. vol 94. issue 447. 2005-08-25. PMID:15895705. |
up to 60% of males with classic fabry disease have cardiac abnormalities, including left ventricular hypertrophy, valvular dysfunction and conduction abnormalities. |
2005-08-25 |
2023-08-12 |
Not clear |
| Cristina Chimenti, Maurizio Pieroni, Emanuela Morgante, Daniela Antuzzi, Andrea Russo, Matteo Antonio Russo, Attilio Maseri, Andrea Frustac. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. vol 110. issue 9. 2005-03-25. PMID:15313943. |
prevalence of fabry disease in female patients with late-onset hypertrophic cardiomyopathy. |
2005-03-25 |
2023-08-12 |
Not clear |
| Cristina Chimenti, Maurizio Pieroni, Emanuela Morgante, Daniela Antuzzi, Andrea Russo, Matteo Antonio Russo, Attilio Maseri, Andrea Frustac. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. vol 110. issue 9. 2005-03-25. PMID:15313943. |
fabry disease (fd) has been recognized as the cause of left ventricular hypertrophy in 6% of men with late-onset hypertrophic cardiomyopathy (hcm). |
2005-03-25 |
2023-08-12 |
Not clear |
| Maurizio Pieroni, Cristina Chimenti, Andrea Russo, Matteo Antonio Russo, Attilio Maseri, Andrea Frustac. Tissue Doppler imaging in Fabry disease. Current opinion in cardiology. vol 19. issue 5. 2005-01-28. PMID:15316452. |
the development of effective enzyme replacement/enhancement therapy makes of clinical relevance considering fabry disease in the differential diagnosis of patients with hypertrophic cardiomyopathy. |
2005-01-28 |
2023-08-12 |
Not clear |
| Masakazu Teragaki, Akemi Tanaka, Kaname Akioka, Hoang Thi Ngkoc Lan, Yasuaki Nishi, Tsunekazu Yamano, Junichi Yoshikaw. Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy. Japanese heart journal. vol 45. issue 4. 2004-10-28. PMID:15353880. |
fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy. |
2004-10-28 |
2023-08-12 |
Not clear |
| K Komamura, M Higashi, N Yamad. Improvement of cardiac hypertrophy and ventricular function in a man with Fabry disease by treatment with recombinant alpha-galactosidase A. Heart (British Cardiac Society). vol 90. issue 6. 2004-06-15. PMID:15145857. |
improvement of cardiac hypertrophy and ventricular function in a man with fabry disease by treatment with recombinant alpha-galactosidase a. |
2004-06-15 |
2023-08-12 |
Not clear |
| Dominique-Paul Germai. [Fabry disease in 2004]. La Revue du praticien. vol 53. issue 20. 2004-05-20. PMID:15018073. |
some phenotypic variants of fabry disease are probably under-diagnosed among patients with so-called idiopathic hypertrophic cardiomyopathy on haemodialysis. |
2004-05-20 |
2023-08-12 |
Not clear |
| Hiroyuki Teraguchi, Toshihiro Takenaka, Aichi Yoshida, Syuhei Taguchi, Kenjiro Ninomiya, Hiroki Yoshida, Michiko Horinouchi, Suguru Yonezawa, Shoichiro Nakao, Shinichi Minagoe, Shuwa Te. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease]. Journal of cardiology. vol 43. issue 2. 2004-04-20. PMID:15046052. |
we have previously reported a 3% prevalence of this cardiac variant in men with left ventricular hypertrophy, which we designated cardiac fabry disease. |
2004-04-20 |
2023-08-12 |
Not clear |
| D E L Wilcke. Overview of inherited metabolic disorders causing cardiovascular disease. Journal of inherited metabolic disease. vol 26. issue 2-3. 2004-03-05. PMID:12889664. |
hypertrophic cardiomyopathy may be confused with fabry disease, for which effective treatment is now available. |
2004-03-05 |
2023-08-12 |
Not clear |
| C-C Yang, L-W Lai, O Whitehair, W-L Hwu, S-C Chiang, Y-H H Lie. Two novel mutations in the alpha-galactosidase A gene in Chinese patients with Fabry disease. Clinical genetics. vol 63. issue 3. 2003-11-12. PMID:12694230. |
the genotype y222x is associated with classic fabry disease, with unexpectedly rapid deterioration of visual acuity, while t410a is associated with a milder fabry disease, with ventricular hypertrophy and neuropathic pain. |
2003-11-12 |
2023-08-12 |
Not clear |
| S R Ommen, R A Nishimura, W D Edward. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? Heart (British Cardiac Society). vol 89. issue 8. 2003-09-02. PMID:12860876. |
fabry disease: a mimic for obstructive hypertrophic cardiomyopathy? |
2003-09-02 |
2023-08-12 |
Not clear |